Apolipoprotein A-II(APO-A2) stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism. It is produced by the liver and is involved in cholesteryl ester formation and cholesterol transport from tissues to the liver. Recent studies have established the interaction between APOA2 -256T>C polymorphism and dietary saturated fatty acids intake in relation to obesity on healthy individuals. Significant interaction between APOA2-saturated fatty acids intake and body mass index (BMI). The result of this study confirmed the interaction between APOA2 -256T>C polymorphism and SFAs intake with BMI in type 2 diabetic patients.
序列
提供的載脂蛋白A-II / APOA2，人類重組Apolipoprotein A-II / APOA2, Human Recombinant是Biovision品牌中國區域總代理艾美捷科技產品，具體的蛋白序列可查看提供的英文版本產品說明書。
來源宿主
提供的載脂蛋白A-II / APOA2，人類重組Apolipoprotein A-II / APOA2, Human Recombinant產品來源宿主，查看該產品說明書，或者在線咨詢我們。
溶解建議
Centrifuge the vial prior to opening. Reconstitute in sterile deionized water to a concentration of 100 μg/ml. Do not vortex. It is recommended to store at -20°C.
